Phase 2 Fabry Disease Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
Fabry Disease
Chiesi Farmaceutici S.p.A.22 enrolled12 locationsNCT06328608
Recruiting
Phase 2Phase 3
Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease
Fabry Disease
Chiesi Farmaceutici S.p.A.16 enrolled10 locationsNCT05710692
Recruiting
Phase 1Phase 2
Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease
Fabry Disease
UniQure Biopharma B.V.12 enrolled8 locationsNCT06270316
Recruiting
Phase 1Phase 2
4D-310 in Adults With Fabry Disease and Cardiac Involvement
Fabry Disease
4D Molecular Therapeutics18 enrolled4 locationsNCT05629559
Recruiting
Phase 2
Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease
Fabry Disease
AceLink Therapeutics, Inc.16 enrolled6 locationsNCT06114329